Another NameIdhifa、LuciEna
IndicationsFor the treatment of patients with acute myeloid leukemia (AML) harboring an isocitrate dehydrogenase-2 (IDH2) mutation.
Reg No.09 L 1019/23
Inspection No.2272-23
WhatsApp:
